Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors

被引：7

作者：

Deharo, Pierre ^{[1
,2
,3
]}

Pankert, Mathieu ^{[1
,2
,3
]}

Quilici, Jacques ^{[1
,2
,3
]}

Bonnet, Guillaume ^{[1
,2
,3
]}

Bassez, Clemence ^{[1
,3
]}

Verdier, Valentine ^{[5
]}

Morange, Pierre ^{[2
,3
,4
]}

Alessi, Marie-Christine ^{[2
,3
,4
]}

Bonnet, Jean-Louis ^{[1
,2
,3
]}

Cuisset, Thomas ^{[1
,2
,3
]}

机构：

[1] CHU Timone, Dept Cardiol, F-13385 Marseille, France

[2] INSERM, UMR1062, Nutr Obes & Risk Thrombosis, F-13385 Marseille, France

[3] Aix Marseille Univ, Fac Med, F-13385 Marseille, France

[4] CHU Timone, Lab Hematol, F-13385 Marseille, France

[5] Assistance Publ Hop Marseille, EMAI, Marseille, France

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 184卷

关键词：

Chronic kidney disease; Platelet reactivity; P2Y12; blockers; Acute coronary syndromes; ACUTE CORONARY SYNDROMES; ANTIPLATELET THERAPY; CLOPIDOGREL; PRASUGREL; REACTIVITY; GUIDELINES;

D O I：

10.1016/j.ijcard.2015.02.077

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：428 / 430

页数：3

共 50 条

[41] Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes [J].

Joshi, Rajiv R. ;

Hossain, Rashed ;

Morton, Allison C. ;

Ecob, Rosemary ;

Judge, Heather M. ;

Wales, Clare ;

Walker, Jemma V. ;

Karunakaran, Arun ;

Storey, Robert F. .

PLATELETS, 2014, 25 (06) :416-422

[42] Impact of Aspirin Dosing on the Effects of P2Y12 Inhibition in Patients with Acute Coronary Syndromes [J].

Mark R. Thomas ;

Robert F. Storey .

Journal of Cardiovascular Translational Research, 2014, 7 :19-28

[43] P2Y12 Inhibitors in Cardiovascular Disease: Focus on Prasugrel [J].

Scott, Day Marice ;

Norwood, Rhonda M. ;

Parra, David .

ANNALS OF PHARMACOTHERAPY, 2009, 43 (01) :64-76

[44] Impact of Aspirin Dosing on the Effects of P2Y12 Inhibition in Patients with Acute Coronary Syndromes [J].

Thomas, Mark R. ;

Storey, Robert F. .

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2014, 7 (01) :19-28

[45] Effect of P2Y12 inhibitors on inflammation and immunity [J].

Thomas, Mark R. ;

Storey, Robert F. .

THROMBOSIS AND HAEMOSTASIS, 2015, 114 (03) :490-497

[46] P2Y12 receptor inhibitors for secondary prevention of ischemic stroke [J].

Liu, Fang ;

Tantry, Udaya S. ;

Gurbel, Paul A. .

EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (08) :1149-1165

[47] Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis [J].

Jain, Nishank ;

Hunt, Suzanne L. ;

Cui, Huizhong ;

Phadnis, Milind A. ;

Mahnken, Jonathan D. ;

Shireman, Theresa I. ;

Dai, Junqiang ;

Mehta, Jawahar L. ;

Rasu, Rafia S. .

CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (05) :511-521

[48] P2Y12 Inhibition in Patients with NSTEMI - Can Later Be Better? [J].

Keaney, John F., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (11) :1056-1057

[49] Residual platelet activation through protease-activated receptors (PAR)-1 and-4 in patients on P2Y12 inhibitors [J].

Eslam, Roza Badr ;

Lang, Irene M. ;

Koppensteiner, Renate ;

Calatzis, Andreas ;

Panzer, Simon ;

Gremmel, Thomas .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) :403-406

[50] Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane [J].

Rabani, Vahideh ;

Montange, Damien ;

Meneveau, Nicolas ;

Davani, Siamak .

PLATELETS, 2018, 29 (07) :709-715

← 1 2 3 4 5 →